Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells
Open Access
- 1 March 2003
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 3 (3), 285-296
- https://doi.org/10.1016/s1535-6108(03)00050-3
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Distinct requirements for Ras oncogenesis in human versus mouse cellsGenes & Development, 2002
- The INK4a/ARF network in tumour suppressionNature Reviews Molecular Cell Biology, 2001
- SV40 and cell cycle perturbations in malignant mesotheliomaSeminars in Cancer Biology, 2001
- Establishment of a Chemical Synthetic Lethality Screen in Cultured Human CellsGenome Research, 2001
- Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the Aα subunit geneOncogene, 2001
- From HER2 to HerceptinCurrent Medical Research and Opinion, 2001
- Induction of Apoptosis by Camptothecin and TopotecanAnnals of the New York Academy of Sciences, 1996
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994
- A new microcellular cytotoxicity test based on calcein AM releaseHuman Immunology, 1993
- The mode of action of the antitumor drug bouvardin, an inhibitor of protein synthesis in eukaryotic cellsFEBS Letters, 1982